| Name | Title | Contact Details |
|---|
Cloud Giants provides consulting services to midsize B2B organizations in the Salesforce ecosystem looking to accelerate revenue operations. Through a unique blend of Salesforce expertise, technical proficiency and business acumen, we drive results and influence meaningful KPIs aligned to your business objectives. Cloud Giants specializes in: Increasing the velocity of revenue operations Reducing friction in the selling process Providing process transparency to all teams involved in the revenue lifecycle Simplifying and automating business processes Enhancing and streamlining the buyer experience Minimizing technical debt and delivering quicker time to value Our expertise includes Revenue Cloud/CPQ, Sales Cloud, and Experience Cloud solutions.
In a time when humanity needs to rethink the future to sustain life on this planet, we consider responsible business a necessary game changer. That is why we are a company that offers 100% organic cotton products for customers who seek delicious, sustainable goods of premium quality. We want our products to last long enough to be passed on. We create them to be enjoyed and used. And we insist on developing a new, sustainable standard of designed goods. #design #functionality #longlasting #newstandard #BCorp #GOTS #organic #feelgood
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
At Divcon Controls, our mission is to provide our customers with cost effective solutions to meet their exact building automation needs. We strive to accomplish this through technology, innovation, and award winning personal service. Simply put, with Divcon Controls and Delta Controls, integration is simplified, customers are satisfied.
F1® returns to the Las Vegas Strip November 21-23, 2024!